GRP and small cell lung carcinoma: Monoclonal antibodies have been developed against circulating bombesin and one such antibody, 2A11, has been shown to inhibit the growth of SCLC in vitro and also as xenografts in nude mice (Chaudry et al, 1999); however, it has limited efficacy in human trials.